The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2022

Filed:

Apr. 02, 2019
Applicants:

Tadashi Tanabe, Osaka, JP;

Keiichi Hukuda, Tokyo, JP;

Takashi Kawakami, Tokyo, JP;

Inventors:

Tadashi Tanabe, Osaka, JP;

Keiichi Hukuda, Tokyo, JP;

Takashi Kawakami, Tokyo, JP;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/76 (2015.01); A61K 31/5585 (2006.01); A61K 38/18 (2006.01); A61K 38/52 (2006.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); C12N 7/00 (2006.01); A61K 35/13 (2015.01);
U.S. Cl.
CPC ...
A61K 35/76 (2013.01); A61K 31/5585 (2013.01); A61K 38/1825 (2013.01); A61K 38/1833 (2013.01); A61K 38/1866 (2013.01); A61K 38/52 (2013.01); A61K 45/06 (2013.01); A61K 48/005 (2013.01); C12N 7/00 (2013.01); C12Y 503/99004 (2013.01); A61K 35/13 (2013.01); C12N 2750/14132 (2013.01); C12N 2750/14143 (2013.01); C12N 2799/025 (2013.01);
Abstract

Drug compositions of angiogenesis therapy contain gene coding for human prostacyclin synthase (hPGIS) synthesizing prostaglandin Iwith activities of vasodialation and/or anti-platelet aggregation; drug compositions contain adeno-associated virus (AAV) inserted with gene for angiogenesis factors. The administration of the drug compositions into the aimed treatment region results in transfer of AAV type 1-hPGIS to skeletal muscles and induces a notable expression of human PGIS gene in skeletal muscles. The PGIis produced by mediation of the gene expression in the muscle cells, secreted, induces vessel-protective, neovascularization and anti-platelet aggregation actions, which lead to an improvement in vascular ischemia.


Find Patent Forward Citations

Loading…